Broad COVID-19 vaccination proves economically beneficial, especially for older adults, highlighting significant health and ...

As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued ...

Clinical trials have shown the mRNA vaccines for COVID-19 are safe and effective, especially at preventing severe illness, ...

L.A. County wastewater shows COVID levels at their highest since February. • The CDC’s reversal on vaccine guidance for ...

The Pennsylvania Commonwealth Court, in a recent published decision, Fee v. Prospect Medical Holdings (Workers’ Compensation ...

Johnson & Johnson’s coronavirus vaccine is administered as a one-dose shot, whereas the Pfizer and Moderna vaccines are administered as two doses, given 21 and 28 days apart, respectively.

So the Dayton Daily News asked local pediatricians and examined the data to answer parents’ most common questions about the benefits and the risks of the COVID vaccine for children. Dayton ...

After more than a year with two types of COVID-19 vaccines in use in the United States, another will be up for consideration by the U.S. Food and Drug Administration this week.

Overall, 2,602,557 individuals received their first dose of the Pfizer COVID-19 vaccine between Dec. 20, 2020, and April 30, 2021. Their mean age was 46.8 years and 51.5% were women.

The benefits of the Johnson & Johnson Janssen coronavirus vaccine still outweigh potential risks, according to data from the US Centers for Disease Control and Prevention.

In its briefing document, the FDA summarized, “The known benefits among vaccine recipients 18 years of age and older relative to placebo are reduction in the risk of mild to severe COVID-19 ...